Skip to content

Clinical trials

Phase 1/2 Myelodysplastic Syndromes trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Phase: Phase 1/2 Country / region: United Kingdom Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20091
20131
20142
20151
20161
20201
20211
20222
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting4
Active, not recruiting1
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca1
BeOne Medicines1
Bellicum Pharmaceuticals1
Celgene1
Cell Medica Ltd1
Chroma Therapeutics1
Constellation Pharmaceuticals1
Ellipses Pharma1
Faron Pharmaceuticals Ltd1
Forma Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute13
Myelodysplastic Syndromes13
Hematologic Neoplasms3
Leukemia3
Leukemia, Myelomonocytic, Chronic3
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Multiple Myeloma2
Myelodysplastic-Myeloproliferative Diseases2
Neoplasms2
Anemia1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.